Prevention of polyphenols against carcinogenesis induced by environmental carcinogens

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 36, Issue 1, 2017, Pages 87-98

  Clementino, Marco ^a   Shi, Xianglin ^b   Zhang, Zhuo ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cancer prevention; Carcinogenesis; Dietary polyphenols; Environmental carcinogens; Heavy metals; Polycyclic aromatic hydrocarbons; Ultraviolet B

Indexed keywords

ARSENIC; CARCINOGEN; CHROMIUM; HEAVY METAL; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL; POLLUTANT; PROTECTIVE AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HUMAN; MALIGNANT NEOPLASM; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION; CHEMICALLY INDUCED; DIET; DRUG EFFECTS; NEOPLASMS; POLLUTANT; TOXICITY;

CARCINOGENESIS; CARCINOGENS, ENVIRONMENTAL; DIET; ENVIRONMENTAL POLLUTANTS; HUMANS; METALS, HEAVY; NEOPLASMS; POLYCYCLIC AROMATIC HYDROCARBONS; POLYPHENOLS; PROTECTIVE AGENTS;

EID: 85017016202     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.2017019057     Document Type: Article

References (160)

1. Amaro-Ortiz A, Yan B, D’Orazio JA. Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation. Molecules. 2014;19(5):6202–19.
2. Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet light. Mutat Res. 2005;571(1–2):19–31.
3. Polefka TG, Meyer TA, Agin PP, Bianchini RJ. Effects of solar radiation on the skin. J Cosmet Dermatol. 2012;11(2):134–43.
4. Tyagi N, Bhardwaj A, Srivastava SK, Arora S, Marimuthu S, Deshmukh SK, Ajay P. Singh AP, Carter JE, Singh S. Development and characterization of a novel in vitro progression model for UVB-induced skin carcinogenesis. Scientif Rept. 2015;5:13894.
5. Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco AJ. The multitude and diversity of environmental carcinogens. Envir Res. 2007;105(3):414–29.
6. Boffetta P. Human cancer from environmental pollutants: The epidemiological evidence. Mutation research/ Genetic toxicology and environmental mutagenesis. 2006;608(2):157–62.
7. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol. 2004;14(6):473–86.
8. Kim D, Dai J, Fai LY, Yao H, Son YO, Wang L, Pratheeshkumar P, Kando K, Shi X, Zhang Z. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development. J Biol Chem. 2015;290(4):2213–24.
9. Lee JC, Son YO, Pratheeshkumar P, Shi X. Oxidative stress and metal carcinogenesis. Free radical biology and medicine. 2012;53(4):742–57.
10. Proctor DM, Suh M, Campleman SL, Thompson CM. Assessment of the mode of action for hexavalent chromium- induced lung cancer following inhalation exposures. Toxicology. 2014;325:160–79.
11. Wang X, Son YO, Chang Q, Sun L, Hitron JA, Budhraja A, Zhang Z, Ke Z, Luo J, Shi X. NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium. Toxicol Sci. 2011;123(2):399–410.
12. Zhang Z, Pratheeshkumar P, Budhraja A, Son YO, Kim D, Shi X. Role of reactive oxygen species in arsenicinduced transformation of human lung bronchial epithelial (BEAS-2B) cells. Biochem Biophys Res Comm. 2015;456(2):643–8.
13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
14. Divya SP, Wang X, Pratheeshkumar P, Son YO, Roy RV, Kim D, Dai J, Hitron JA, Wang L, Asha P, Shi X, Zhang Z. Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NFkappaB signaling pathways in SKH-1 mice skin. Toxicol Appl Pharmacol. 2015;284(1):92–9.
15. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nature Rev Cancer. 2011;11(3):211–8.
16. Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, Kim JH, Gupta SC, Phromnio K, Sundaram C, Prasad S, Chaturvedi MM, Sung B. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr Drug Targets. 2011;12(11):1595–653.
17. Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs. 2007;16(11):1753–73.
18. Shimoi K, Masuda S, Shen B, Furugori M, Kinae N. Radioprotective effects of antioxidative plant flavonoids in mice. Mutat Res. 1996;350(1):153–61.
19. Yang HM, Ham YM, Yoon WJ, Roh SW, Jeon YJ, Oda T, Kang SM, Kang MC, Kim EA, Kim D, Kim KN. Quercitrin protects against ultraviolet B-induced cell death in vitro and in an in vivo zebrafish model. J Photochem Photobiol B Biol. 2012;114:126–31.
20. Martin DA, Bolling BW. A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases. Food Function. 2015;6(6):1773–86.
21. Farzaei MH, Abdollahi M, Rahimi R. Role of dietary polyphenols in the management of peptic ulcer. World J Gastroenterol. 2015;21(21):6499–517.
22. Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L. Roles of resveratrol and other grape-derived polyphenols in Alzheimer’s disease prevention and treatment. Biochim Biophys Acta. 2015;1852(6):1202–8.
23. Lakey-Beitia J, Berrocal R, Rao KS, Durant AA. Polyphenols as therapeutic molecules in Alzheimer’s disease through modulating amyloid pathways. Molec Neurobiol. 2015;51(2):466–79.
24. Fernandez-Arroyo S, Camps J, Menendez JA, Joven J. Managing hypertension by polyphenols. Planta Medica. 2015;81(8):624–9.
25. Gormaz JG, Valls N, Sotomayor C, Turner T, Rodrigo R. Potential role of polyphenols in the prevention of cardiovascular diseases: molecular bases. Curr Med Chem. 2016;23(2):115–28.
26. Xiao JB, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015;22(1):23–38.
27. Dragan S, Andrica F, Serban MC, Timar R. Polyphenolsrich natural products for treatment of diabetes. Curr Med Chem. 2015;22(1):14–22.
28. Fantini M, Benvenuto M, Masuelli L, Frajese GV, Tresoldi I, Modesti A, Bei R. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Molec Sci. 2015;16(5):9236–82.
29. Wang J, Tang L, Wang JS. Biomarkers of dietary polyphenols in cancer studies: current evidence and beyond. Oxidat Med Cell Longev. 2015;2015:732302.
30. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letts. 2008;269(2):199–225.
31. Firdous AB, Sharmila G, Balakrishnan S, RajaSingh P, Suganya S, Srinivasan N, Arunakaran J. Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway. Food & Function. 2014;5(10):2632–45.
32. Han MH, Lee WS, Jung JH, Jeong JH, Park C, Kim HJ, Kim G, Jung JM, Kwon TK, Kim GY, Ryu CH, Shin SC, Hong SC, Choi YH. Polyphenols isolated from Allium cepa L. induces apoptosis by suppressing IAP-1 through inhibiting PI3K/Akt signaling pathways in human leukemic cells. Food Chem Toxicol. 2013;62:382–9.
33. Lamy S, Akla N, Ouanouki A, Lord-Dufour S, Beliveau R. Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway. Exper Cell Res. 2012;318(13):1586–96.
34. Chiu CT, Chen JH, Chou FP, Lin HH. Hibiscus sabdariffa leaf extract inhibits human prostate cancer cell invasion via down-regulation of Akt/NF-kB/MMP-9 pathway. Nutrients. 2015;7(7):5065–87.
35. Zhou Q, Bennett LL, Zhou S. Multifaceted ability of naturally occurring polyphenols against metastatic cancer. Clin Exper Pharmacol Physiol. 2016;43(4):394–409.
36. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727–47.
37. Middleton E, Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52(4):673–751.
38. Beckman CH. Phenolic-storing cells: keys to programmed cell death and periderm formation in wilt disease resistance and in general defence responses in plants? Physiol Molec Plant Pathol. 2000;57(3):101–10.
39. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidat Med Cell Longev. 2009;2(5):270–8.
40. Perez-Jimenez J, Neveu V, Vos F, Scalbert A. Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr. 2010;64 Suppl 3:S112–20.
41. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(1 Suppl):215s–7s.
42. Bikle DD. Protective actions of vitamin D in UVB induced skin cancer. Photochem Photobiol Sci. 2012;11(12):1808–16.
43. Afaq F, Katiyar SK. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem. 2011;11(14):1200–15.
44. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol. 2001;176(2):110–7.
45. Afaq F, Adhami VM, Ahmad N, Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene. 2003;22(7):1035–44.
46. Afaq F, Ahmad N, Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene. 2003;22(58):9254–64.
47. Vayalil PK, Elmets CA, Katiyar SK. Treatment of green tea polyphenols in hydrophilic cream prevents UVBinduced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis. 2003;24(5):927–36.
48. Katiyar SK, Mukhtar H. Green tea polyphenol (-)-epigallocatechin- 3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen- presenting cells, and oxidative stress. J Leukocyte Biol. 2001;69(5):719–26.
49. Katiyar SK, Afaq F, Perez A, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis. 2001;22(2):287–94.
50. Katiyar SK, Vaid M, van Steeg H, Meeran SM. Green tea polyphenols prevent UV-induced immunosuppression by rapid repair of DNA damage and enhancement of nucleotide excision repair genes. Cancer Prev Res. 2010;3(2):179–89.
51. Meeran SM, Mantena SK, Elmets CA, Katiyar SK. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res. 2006;66(10):5512–20.
52. Mantena SK, Meeran SM, Elmets CA, Katiyar SK. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J Nutr. 2005;135(12):2871–7.
53. Meeran SM, Akhtar S, Katiyar SK. Inhibition of UVBinduced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Investig Dermatol. 2009;129(5):1258–70.
54. Pacheco-Palencia LA, Noratto G, Hingorani L, Talcott ST, Mertens-Talcott SU. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J Agric Food Chem. 2008;56(18):8434–41.
55. Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H. Protective effect of pomegranate-derived products on UVBmediated damage in human reconstituted skin. Exper Dermatol. 2009;18(6):553–61.
56. Afaq F, Khan N, Syed DN, Mukhtar H. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH- 1 hairless mouse epidermis. Photochem Photobiol. 2010;86(6):1318–26.
57. Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol. 2005;81(1):38–45.
58. Afaq F, Zaid M, Khan N, Syed D, Yun JM, Sarfaraz S, Suh Y, Mukhtar H. Inhibitory effect of oral feeding of pomegranate fruit extract on UVB-induced skin carcinogenesis in SKH-1 hairless mice. Cancer Res. 2008;68(9 Suppl):1246.
59. Mantena SK, Katiyar SK. Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Rad Biol Med. 2006;40(9):1603–14.
60. Sharma SD, Meeran SM, Katiyar SK. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-kappaB signaling in in vivo SKH-1 hairless mice. Molec Cancer Therapeut. 2007;6(3):995–1005.
61. Vaid M, Sharma SD, Katiyar SK. Proanthocyanidins inhibit photocarcinogenesis through enhancement of DNA repair and xeroderma pigmentosum group A-dependent mechanism. Cancer Prev Res. 2010;3(12):1621–9.
62. Sharma SD, Katiyar SK. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12. Carcinogenesis. 2006;27(1):95–102.
63. Adhami VM, Afaq F, Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia. 2003;5(1):74–82.
64. Kim KH, Back JH, Zhu Y, Arbesman J, Athar M, Ko pelovich L, Kim Al, Bickers DR. Resveratrol targets transforming growth factor-beta2 signaling to block UV-induced tumor progression. J Investig Dermatol. 2011;131(1):195–202.
65. Afaq F, Adhami VM, Ahmad N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol. 2003;186(1):28–37.
66. Singh RP, Dhanalakshmi S, Mohan S, Agarwal C, Agarwal R. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells. Molec Cancer Therapeut. 2006;5(5):1145–53.
67. Gu M, Dhanalakshmi S, Mohan S, Singh RP, Agarwal R. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis. 2005;26(8):1404–13.
68. Gu M, Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res. 2007;67(7):3483–91.
69. Katiyar SK. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int J Oncol. 2002;21(6):1213–22.
70. Katiyar SK, Meleth S, Sharma SD. Silymarin, a flavonoid from milk thistle (Silybum marianum L.), inhibits UV-induced oxidative stress through targeting infiltrating CD11b+ cells in mouse skin. Photochem Photobiol. 2008;84(2):266–71.
71. Kelly GS. Quercetin. Monograph. Alt Med Rev. 2011;16(2):172–94.
72. Yin Y, Li W, Son YO, Sun L, Lu J, Kim D, Wang X, Yao H, Wang L, Pratheeshkumar P, Hitron AJ, Luo J, Gao N, Shi X, Zhang Z. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol Appl Pharmacol. 2013;269(2):89–99.
73. Vicentini FT, He T, Shao Y, Fonseca MJ, Verri WA, Jr., Fisher GJ, Xu Y. Quercetin inhibits UV irradiation-induced inflammatory cytokine production in primary human keratinocytes by suppressing NF-kappaB pathway. J Dermatol Sci. 2011;61(3):162–8.
74. Casagrande R, Georgetti SR, Verri WA, Jr., Dorta DJ, dos Santos AC, Fonseca MJ. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B Biol. 2006;84(1):21–7.
75. Morand C, Manach C, Crespy V, Remesy C. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Rad Res. 2000;33(5):667–76.
76. Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH, Shi X. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem. 2006;281(25):17359–68.
77. Xu M, Bower KA, Wang S, Frank JA, Chen G, Ding M, Wang S, Shi X, Ke Z, Luo J. Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. Molec Cancer. 2010;9:285.
78. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF, Hsieh YS. Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer. 2005;53(2):232–43.
79. Cimino F, Ambra R, Canali R, Saija A, Virgili F. Effect of cyanidin-3-O-glucoside on UVB-induced response in human keratinocytes. J Agric Food Chem. 2006;54(11):4041–7.
80. Pratheeshkumar P, Son YO, Wang X, Divya SP, Joseph B, Hitron JA, Wang L, Kim D, Yin Y, Roy RV, Lu J, Zhang Z, Wang Y, Shi X. Cyanidin-3-glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-kappaB signaling pathways in SKH-1 hairless mice skin. Toxicol Appl Pharmacol. 2014;280(1):127–37.
81. Brown JR, Thornton JL. Percivall Pott (1714–1788) and chimney sweepers’ cancer of the scrotum. Brit J Indust Med. 1957;14(1):68–70.
82. Ellard S, Mohammed Y, Dogra S, Wolfel C, Doehmer J, Parry JM. The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays. Mutagenesis. 1991;6(6):461–70.
83. Nebert DW. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol. 1989;20(3):153–74.
84. Murray IA, Flaveny CA, DiNatale BC, Chairo CR, Schroeder JC, Kusnadi A, Perdew GH. Antagonism of aryl hydrocarbon receptor signaling by 6,2’,4’-trimethoxyflavone. J Pharmacol Exper Therapeut. 2010;332(1):135–44.
85. Buters JTM, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Nat Acad Sci U S A. 1999;96(5):1977–82.
86. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Nat Acad Sci U S A. 2000;97(2):779–82.
87. Besaratinia A, Pfeifer GP. Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation. Cancer Res. 2003;63(24):8708–16.
88. Benzo[a]pyrene. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. 1983;32:211–24.
89. Banerjee S, Manna S, Saha P, Panda CK, Das S. Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev. 2005;14(3):215–21.
90. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol. 2003;23(4):255–61.
91. Banerjee S, Manna S, Mukherjee S, Pal D, Panda CK, Das S. Black tea polyphenols restrict benzopyrene-induced mouse lung cancer progression through inhibition of Cox-2 and induction of caspase-3 expression. Asia Pac J Cancer Prev. 2006;7(4):661–6.
92. Wen X, Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis. 2005;26(10):1774–81.
93. Lee JE, Safe S. 3’,4’-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol Sci. 2000;58(2):235–42.
94. Tsuji PA, Walle T. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis. 2006;27(8):1579–85.
95. Ciolino HP, Yeh GC. Inhibition of aryl hydrocarboninduced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Molec Pharmacol. 1999;56(4):760–7.
96. Ciolino HP, Daschner PJ, Yeh GC. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 1998;58(24):5707–12.
97. Berge G, Ovrebo S, Eilertsen E, Haugen A, Mollerup S. Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Brit J Cancer. 2004;91(7):1380–3.
98. Smith WA, Freeman JW, Gupta RC. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7. Mutat Res. 2001;480–481:97–108.
99. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem. 2001;82(3):387–98.
100. Chan HY, Wang H, Tsang DS, Chen ZY, Leung LK. Screening of chemopreventive tea polyphenols against PAH genotoxicity in breast cancer cells by a XRE-luciferase reporter construct. Nutr Cancer. 2003;46(1):93–100.
101. Roy P, George J, Srivastava S, Tyagi S, Shukla Y. Inhibitory effects of tea polyphenols by targeting cyclooxygenase- 2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors. Investig New Drug. 2011;29(2):225–31.
102. Williams SN, Shih H, Guenette DK, Brackney W, Denison MS, Pickwell GV, Quattrochi LC. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem-Biol Interact. 2000;128(3):211–29.
103. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res. 2007;67(24):11742–50.
104. Ciolino HP, Daschner PJ, Yeh GC. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J. 1999;340 (Pt 3):715-22.
105. Kumaraguruparan R, Seshagiri PB, Hara Y, Nagini S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobioticmetabolizing enzymes, oxidative stress, cell proliferation, apoptosis, and angiogenesis. Molec Carcinogen. 2007;46(9):797–806.
106. Roy P, Nigam N, George J, Srivastava S, Shukla Y. Induction of apoptosis by tea polyphenols mediated through mitochondrial cell death pathway in mouse skin tumors. Cancer Biol Ther. 2009;8(13):1281–7.
107. Cancer IAfRo. Arsenic, metals, fibres and dusts. Lyon, France: International Agency for Res on Cancer. 2012; 526 p.
108. Chen F, Castranova V, Li Z, Karin M, Shi X. Inhibitor of nuclear factor kappaB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic. Cancer Res. 2003;63(22):7689–93.
109. Gao N, Shen L, Zhang Z, Leonard SS, He H, Zhang XG, Shi X, Jiang BH. Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Molec Cell Biochem. 2004;255(1–2):33–45.
110. Harris GK, Shi X. Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutation Res. 2003;533(1–2):183–200.
111. Leonard SS, Harris GK, Shi X. Metal-induced oxidative stress and signal transduction. Free Rad Biol Med. 2004;37(12):1921–42.
112. Qian Y, Liu KJ, Chen Y, Flynn DC, Castranova V, Shi X. Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization. J Biol Chem. 2005;280(5):3875–84.
113. Shi H, Hudson LG, Ding W, Wang S, Cooper KL, Liu S, Chen Y, Shi X, Liu KJ. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol. 2004;17(7):871–8.
114. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. Risk of internal cancers from arsenic in drinking water. Envir Health Perspect. 2000;108(7):655–61.
115. Steinmaus C, Moore L, Hopenhayn-Rich C, Biggs ML, Smith AH. Arsenic in drinking water and bladder cancer. Cancer Invest. 2000;18(2):174–82.
116. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC, Chen CJ. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Letts. 2003;137(1–2):15–21.
117. National Research Council Subcommittee to Update the Arsenic in Drinking Water R. Arsenic in Drinking Water: 2001 Update. Washington, DC: National Academies Press (US) by the National Academy of Sciences; 2001.
118. Martinez VD, Vucic EA, Becker-Santos DD, Gil L, Lam WL. Arsenic exposure and the induction of human cancers. J Toxicol. 2011;2011:431287.
119. Mukherjee S, Roy M, Dey S, Bhattacharya RK. A mechanistic approach for modulation of arsenic toxicity in human lymphocytes by curcumin, an active constituent of medicinal herb Curcuma longa Linn. J Clin Biochem Nutr. 2007;41(1):32–42.
120. Sinha D, Dey S, Bhattacharya RK, Roy M. In vitro mitigation of arsenic toxicity by tea polyphenols in human lymphocytes. J Environ Pathol Toxicol Oncol. 2007;26(3):207–20.
121. Acharyya N, Sajed Ali S, Deb B, Chattopadhyay S, Maiti S. Green tea (Camellia sinensis) alleviates arsenic-induced damages to DNA and intestinal tissues in rat and in situ intestinal loop by reinforcing antioxidant system. Environ Toxicol. 2015;30(9):1033–44.
122. Raihan SZ, Chowdhury AK, Rabbani GH, Marni F, Ali MS, Nahar L, Sarker SD. Effect of aqueous extracts of black and green teas in arsenic-induced toxicity in rabbits. Phytother Res. 2009;23(11):1603–8.
123. Sinha D, Roy S, Roy M. Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice. Food Chem Toxicol. 2010;48(4):1032–9.
124. Sinha D, Roy M. Antagonistic role of tea against sodium arsenite-induced oxidative DNA damage and inhibition of DNA repair in Swiss albino mice. J Environ Pathol Toxicol Oncol. 2011;30(4):311–22.
125. Wang L, Kuang L, Hitron JA, Son YO, Wang X, Budhraja A, Lee JC, Pratheeshkumar P, Chen G, Zhang Z, Luo J, Shi X. Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression. Toxicol Appl Pharmacol. 2013;272(1):108–16.
126. Son YO, Pratheeshkumar P, Roy RV, Hitron JA, Wang L, Divya SP, Xu M, Luo J, Chen G, Zhang Z, Shi X. Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis. J Biol Chem. 2015;290(45):27090–100.
127. Du Y, Villeneuve NF, Wang XJ, Sun Z, Chen W, Li J, Lou H, Wong PK, Zhang DD. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ Health Perspect. 2008;116(9):1154–61.
128. Tao S, Zheng Y, Lau A, Jaramillo MC, Chau BT, Lantz RC, Wong PK, Wondrak GT, Zhang DD. Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxidants Redox Signal. 2013;19(14):1647–61.
129. Chromium, nickel, and welding. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. 1990;49:1–648.
130. Machle W, Gregorius F. Cancer of the respiratory system in the United States chromate producing industry. Public Health Repts. 1948;63(35):1114–27.
131. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Indust Med. 1990;17(2):189–215.
132. Langard S. Role of chemical species and exposure characteristics in cancer among persons occupationally exposed to chromium compounds. Scand J Work Environ Health. 1993;19 Suppl 1:81–9.
133. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis. 2000;21(4):533–41.
134. Simonato L, Fletcher AC, Andersen A, Anderson K, Becker N, Chang-Claude J, Ferro G, Gerin M, Gray CN, Hansen KS. A historical prospective study of European stainless steel, mild steel, and shipyard welders. Brit J Indust Med. 1991;48(3):145–54.
135. Sorahan T, Burges DC, Hamilton L, Harrington JM. Lung cancer mortality in nickel/chromium platers, 1946–95. Occupat Environ Med. 1998;55(4):236–42.
136. Wilbur S, Abadin H, Fay M, Yu D, Tencza B, Ingerman L, Klotzbach J, James S. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profiles. Toxicological profile for chromium. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2012.
137. Pellerin C, Booker SM. Reflections on hexavalent chromium: health hazards of an industrial heavyweight. Environ Health Persp. 2000;108(9):A402–7.
138. Woodruff TJ, Axelrad DA, Caldwell J, Morello-Frosch R, Rosenbaum A. Public health implications of 1990 air toxics concentrations across the United States. Environ Health Persp. 1998;106(5):245–51.
139. Costa M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit Rev Toxicol. 1997;27(5):431–42.
140. Shi XL, Dalal NS. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Comm. 1989;163(1):627–34.
141. Shi XL, Dalal NS. Evidence for a Fenton-type mechanism for the generation of.OH radicals in the reduction of Cr(VI) in cellular media. Arch Biochem Biophys. 1990;281(1):90–5.
142. Stohs SJ, Bagchi D, Hassoun E, Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol. 2000;19(3):201–13.
143. Ye J, Zhang X, Young HA, Mao Y, Shi X. Chromium(VI)- induced nuclear factor-kappa B activation in intact cells via free radical reactions. Carcinogenesis. 1995;16(10):2401–5.
144. Yao H, Guo L, Jiang BH, Luo J, Shi X. Oxidative stress and chromium(VI) carcinogenesis. J Environ Pathol Toxicol Oncol. 2008;27(2):77–88.
145. Leonard SS, Harris GK, Shi X. Metal-induced oxidative stress and signal transduction. Free Rad Biol Med. 2004;37(12):1921–42.
146. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Comm. 2003;309(4):1017–26.
147. Wu F, Sun H, Kluz T, Clancy HA, Kiok K, Costa M. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012;258(2):166–75.
148. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase- 2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr. 2006;136(6):1517–21.
149. Tang X, Wang H, Fan L, Wu X, Xin A, Ren H, Wang XJ. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Free Rad Biol Med. 2011;50(11):1599–609.
150. Zhang YC, Gan FF, Shelar SB, Ng KY, Chew EH. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury. Food Chem Toxicol. 2013;59:272–80.
151. Pratheeshkumar P, Son YO, Divya SP, Roy RV, Hitron JA, Wang L, Kim D, Dai J, Asha P, Zhang Z, Wang Y, Shi X. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways. Toxicol Appl Pharmacol. 2014;281(2):230–41.
152. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans. 2009;37(Pt 4):918–25.
153. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, Brunner N, Baker A, Moller S, Nielsen HJ. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exper Metastasis. 2011;28(1):27–38.
154. Venturutti L, Romero LV, Urtreger AJ, Chervo MF, Cordo Russo RI, Mercogliano MF, Inurrigarro G, Pereyra MG, Proietti CJ, Izzo F, Diaz Flaque MC, Sundblad V, Roa JC, Guzmán P, Bal de Kier Joffe ED, Charreau EH, Schillaci R, Elizalde PV. Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR- 21 expression, PDCD4 downregulation and breast cancer metastasis. Oncogene. 2016;35(17):2208–22.
155. Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Comm. 2009;383(3):280–5.
156. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S, Colburn NH. Differentially expressed protein Pdcd4 inhibits tumor promoterinduced neoplastic transformation. Proc Nat Acad Sci U S A. 1999;96(24):14037–42.
157. Young MR, Santhanam AN, Yoshikawa N, Colburn NH. Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Molec Interven. 2010;10(2):76–9.
158. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005;65(14):6034–41.
159. Pratheeshkumar P, Son YO, Divya SP, Wang L, Turcios L, Roy RV, Hiltron JA, Kim D, Dai J, Asha P, Zhang Z, Shi X. Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget. 2016.
160. Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Molec Cancer Therapeut. 2009;8(6):1409–20.